Monday, March 25, 2013 – Major Stock Market Headlines, Biggest Losers, Highest Stock Gainers, Top Advancers & Decliners.
Stock Market Headlines
“U.S. stocks fell, after the S&P Index rose to within a point of its record high, amid concern Cyprus’s bank-restructuring plan will pave the way for losses on deposits in other European nations.“
The DOW (DJIA) dropped 64.28 points to end the day at 14,447.75, while the S&P and Nasdaq both fell 0.30%. There were 1,777 stock decliners on the NYSE versus 1,233 advancers. On the Nasdaq, there were 1,269 decliners versus 1,158 advancers.
Most Active Stocks – Top Gainers by Percentage (NYSE & NASDAQ)
- Horizon Pharma (HZNP) stock soared 14.29% making it the highest gainer (by percentage points) across the NYSE and Nasdaq.
- China Hydroelectric Corporation was the next highest gainer, rising11.30%.
- Shares of ACADIA Pharmaceuticals (ACAD) stock were the third highest gainers, rising 9.78% to end the day at $8.31.
Most Active Stocks – Top Losers by Percentage (NYSE & NASDAQ)
- Idenix Pharmaceuticals was the biggest stock loser across the NYSE and Nasdaq. The stock plunged 19.78% to close the day at $3.69. The company’s “shares sank Monday after the U.S. Patent and Trademark Office determined a competitor was the first to request a patent for a hepatitis therapy.”
- Shares of PGT, Inc. stock dropped 13.95%, making it the second biggest loser. The firm announced a “filing of registration statement for possible sale of shares by a major stakeholder (JLL Partners Fund IV).”
- Halozyme Therapeutics was next in line with its stock dropping 12.25% to be the third top loser across the Nasdaq and NYSE.
Good luck in your investing. Let us know if you have any questions, comments or feedback,
MarketConsensus Stock Analysis Team
Stay In Touch:
Google + (Connect with Us on Google+)
Twitter (Follow Us on Twitter)
Facebook (Like Us on Facebook)
————————————————————————————————-
[related2][/related2]
Financial Market Data powered by Quotemedia.com. All rights reserved. Quote data delayed 15 minutes unless otherwise indicated. View the Terms of Use. Data was also obtained from The Wall Street Journal
